Dose to the penile bulb and individual patient anatomy are predictive of erectile dysfunction in men treated with 125I low dose rate brachytherapy for localized prostate cancer.
CONCLUSION: The most predictive factor of 3yED was the dose to the PB. This may be explained by variation in individual patients' anatomy and this could allow for the development of better strategies to prevent ED.
PMID: 30761939 [PubMed - as supplied by publisher]
Source: Acta Oncologica - Category: Cancer & Oncology Authors: Chasseray M, Dissaux G, Bourbonne V, Boussion N, Goasduff G, Malloreau J, Malhaire JP, Fournier G, Tissot V, Pradier O, Valeri A, Schick U Tags: Acta Oncol Source Type: research
More News: Adenocarcinoma | Anatomy | Brachytherapy | Brain | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Computers | Diabetes | Endocrinology | Erectile Dysfunction | Heart | Impotence | Neurology | Penile Cancer | Prostate Cancer | Ultrasound